ɬÀï·¬

Event

Killam Seminar Series: Turning the Oxygen and Vitamin Dials

Tuesday, March 17, 2026 16:00to17:00
Montreal Neurological Institute de Grandpre Communications Centre, The Neuro, 3801 rue University, Montreal, QC, H3A 2B4, CA

Supported by the generosity of the Killam Trusts, The Neuro's Killam Seminar Series invites outstanding guest speakers whose research is of interest to the scientific community at The Neuro and ɬÀï·¬.


To watch online, clickÌý

Host: Heidi McBride


Studying Memory for Natural Events Across Multiple Timescales

Abstract: Oxygen deprivation (hypoxia) and excess (hyperoxia) are both toxic to humans. Oxygen deprivation contributes to 3 of the 5 leading causes of mortality in developed nations -- heart attack, stroke, and respiratory failure. On the other hand, hyperoxia is toxic to nearly all organisms and contributes to the pathology of ischemia-reperfusion injury, mitochondrial disease and hyperoxic lung injury. However, the molecular mechanisms underlying hypoxia and hyperoxia toxicity remain unknown. By deciphering these mechanisms, we strive to nominate novel therapeutic candidates. Our recent work highlights such mechanisms of hyperoxia toxicity and the cycle of damage caused by destabilization of specific iron-containing protein complexes. While small molecules and biologics are the most common forms of therapy, we believe we have uncovered a new mode of treating metabolic disorders. We now hope to extend our findings to additional inborn errors of metabolism, as well as more common metabolic disorders, including aging and age-associated damage.

Isha Jain

Associate Professor, Biochemistry and Biophysics, UCSF, USA

Ìý

Photo of Isha Jain, PhDIsha received her undergraduate degree in Chemical and Physical Biology from Harvard University. There, she worked in the lab of Erin O’Shea on bacterial chromosome segregation. Subsequently, she joined the Harvard-MIT Program in Health Sciences and Technology. During her PhD, she worked in the Ìý labs of Vamsi Mootha and Warren Zapol, where she discovered that hypoxia could serve as a therapy for mitochondrial disorders. This work led to a Phase 1 clinical trial. Isha began as a UCSF Sandler Faculty Fellow and then joined the Gladstone Institutes and UCSF in 2021. She has received the NIH Early Independence Grant, Searle Scholar Award, Klingenstein-Simons Award, Mallinckrodt Award, TRDRP New Investigator Award, AFAR Junior Faculty Award, Hillblom Start-Up Grant, Keck Medical Research Grant, and Arc Innovation Investigator Award.

The Neuro logoÌýɬÀï·¬ logo

Ìý

The Neuro (Montreal Neurological Institute-Hospital)Ìýis a bilingual academic healthcare institution. We are aÌýɬÀï·¬ research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the ɬÀï·¬ Health Centre.ÌýWe areÌýproud to be a Killam Institution, supported by the Killam Trusts.

Ìý

Ìý

Back to top